Clinical Trial Update: A Dose-response Study With Strontium Malonate in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial of strontium malonate in postmenopausal women with osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Strontium malonate (strontium malonate)

Snippet

Sponsor: Osteologix | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED